United States · FDA National Drug Code directory
Ambelvist
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-332_7c4d8f12-64e0-465f-9b4b-99700e141feb
- Product NDC
- 50419-332
- Form
- INJECTION
- Composition / generic term
- Gadoquatrane
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260612
- Source listing expiry
- 20271231
Source-listed ingredients
- GADOQUATRANE — 257.9 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE in 1 CARTON (50419-332-11) / 15 mL in 1 SYRINGE (50419-332-01) · 50419-332-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →